Collaborate Disseminate
In what has already been tagged as a “game-changer” for cancer treatment, the potent once-a-day tablet known as divarasib has continued to impress at Phase 1b trial stage, outperforming not just current therapies but its previous trial results.Continue… Continue reading Once-a-day pill for stubborn cancer delivers a 62.5% positive response
Copper is not new to medicine, having been used in infection-fighting nanoparticles and implants, among many other innovations. However, it hasn’t quite been used in the way some chemists from the University of California Los Angeles (UCLA) have achiev… Continue reading Cheap drugs may be within reach thanks to copper chemistry discovery
Researchers have developed an automated platform that they’ve used to screen thousands of drugs and identify those that can be used to interrupt the spread of melanoma, one of which they successfully trialed on mice. The approach could help identify pr… Continue reading New tech screens & identifies drugs capable of stopping melanoma spread
Managing diabetes usually involves regular shots of insulin or other drugs, but soon patients might only need to inject themselves a few times a year. Stanford has developed a hydrogel-based delivery system that slowly releases drugs over months to con… Continue reading Slow-release diabetes drugs could cut shots from daily to 3 times a year
A large study into the effectiveness of migraine medications has found that some well-established, cheaper medications are just as effective at preventing migraines as the first-line treatment or newer, more expensive drugs. The findings provide option… Continue reading Comparison of preventive migraine meds shows cheap is just as effective
People with high blood pressure may soon be able to swap the daily pills for an injection every few months. A phase 2 clinical trial has shown that a drug called Zilebesiran can drastically reduce blood pressure for long periods of time with no side ef… Continue reading New drug given every few months reduces high blood pressure in trial
A new study has found that specific regions of the brain are activated after a drug is taken intravenously but not when the same drug is taken orally, with increased activity correlating to an increased feeling of euphoria. The findings could lead to n… Continue reading Specific brain regions activated by IV drug use but not oral, study finds
The US has officially got a homegrown hero in the burgeoning global industry of effective weight-loss treatments, with the FDA approval of Eli Lilly’s Zepbound. The company has announced the once-a-week injectable drug’s cost, dosages, insurance subsid… Continue reading US and UK give the green light to powerful weight loss drug
They’ve been approved for the US market since 2012, but Janus kinase (JAK) inhibitors are still the new kid on the block in terms of rheumatoid arthritis treatment. As such, the real-world evidence on this class of drugs is scarce compared to establish… Continue reading Newer rheumatoid arthritis drugs work well in the real world
Captagon is at the center of a long-debunked myth about militant violence in the Middle East. Continue reading U.S. and Israeli Officials Claim Hamas Was High During Oct. 7 Attack. Is It True?